ConductScience.org, home

Paper8302763

Dose proportionality and population characteristics of oral fadrozole hydrochloride, an aromatase inhibitor, in postmenopausal women.

Kochak GM and 2 others. Pharm Res, 1993. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Dose proportionality and population characteristics of oral fadrozole hydrochloride, an aromatase inhibitor, in postmenopausal women. Papers, record 8302763. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8302763

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Dose proportionality and population characteristics of oral fadrozole hydrochloride, an aromatase inhibitor, in postmenopausal women.
PubMed
Journal
Pharm Res
PubMed
Year
1993
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.2
iCite
Revised in PubMed
2026-10-16
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kochak GMG M
2Choi RLR L
3Entwistle EAE A

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Aromatase InhibitorsMajor topic
FadrozoleMajor topic
Adult
Aged
Aging
Body Height
Body Weight
Female
Humans
Middle Aged
Prospective Studies

Source PubMed

Download CSV of topics

References14

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11356733Effects of low-density lipoprotein and ethinyl estradiol on cyclosporine metabolism in isolated rat liver perfusions.Drug Metab Dispos1992https://conductscience.org/library/papers/1356733PubMed
22150591CGS 16949A, a new aromatase inhibitor in the treatment of breast cancer--a phase I study.Ann Oncol1990https://conductscience.org/library/papers/2150591PubMed
32146284The pharmacodynamic inhibition of estrogen synthesis by fadrozole, an aromatase inhibitor, and its pharmacokinetic disposition.J Clin Endocrinol Metab1990https://conductscience.org/library/papers/2146284PubMed
4925482Effects of ethinyl estradiol on hepatic microsomal proteins and the turnover of cytochrome P-450.J Lab Clin Med1977https://conductscience.org/library/papers/925482PubMed
5901418Decreased liver cytochrome P-450 in rats caused by norethindrone or ethynyloestradiol.Biochem J1977https://conductscience.org/library/papers/901418PubMed
62521224Inhibition of aromatase with CGS 16949A in postmenopausal women.J Clin Endocrinol Metab1989https://conductscience.org/library/papers/2521224PubMed
72137721A phase I trial of CGS 16949A. A new aromatase inhibitor.Cancer1990https://conductscience.org/library/papers/2137721PubMed
83456482Androgen and estrogen metabolism: relationship to obesity.Metabolism1986https://conductscience.org/library/papers/3456482PubMed
93285175Oxidation of 17 alpha-ethynylestradiol by human liver cytochrome P-450.Mol Pharmacol1988https://conductscience.org/library/papers/3285175PubMed
10629289Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer.Am J Obstet Gynecol1978https://conductscience.org/library/papers/629289PubMed
112748520Intra- and intersubject variability: mixed-effects statistical analysis of repeated doses of an angiotensin converting enzyme inhibitor, CGS 16617.Pharm Res1989https://conductscience.org/library/papers/2748520PubMed
121535443Population characteristics of biological systems influenced by multicomponent random and uniform variation.Pharm Res1992https://conductscience.org/library/papers/1535443PubMed
138298071The effect of food on the relative bioavailability of fadrozole hydrochloride.Biopharm Drug Dispos1993https://conductscience.org/library/papers/8298071PubMed
141133154Production of estrone and fractional conversion of circulating androstenedione to estrone in women with endometrial carcinoma.J Clin Endocrinol Metab1975https://conductscience.org/library/papers/1133154PubMed

Download CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
15568891Effects of food on the clinical pharmacokinetics of anticancer agents: underlying mechanisms and implications for oral chemotherapy.Clin Pharmacokinet2004https://conductscience.org/library/papers/15568891PubMed
12844324Clinical pharmacokinetics of aromatase inhibitors and inactivators.Clin Pharmacokinet2003https://conductscience.org/library/papers/12844324PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CYP19A11588PubTator's text mininghttps://conductscience.org/library/genes/1588

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8302763

GET https://conductscience.org/api/papers/v1/8302763/authors